Όλο το DSpace

Πλοήγηση ανά Θέμα "fibrinolytic therapy"

Αποτελέσματα 1-17 από 17

    • Access of stroke patients' to optimal healthcare technology in Greece: Messages to policy makers 

      Siskou O., Korompoki E., Ntaios G., Tsampalas E., Alexopoulou H., Kalliontzakis I., Kouridaki A., Tountopoulou A., Kouzi I., Vasilopoulou S., Milionis H., Evaggelou H., Karagkiozi E., Hatzitolios A.I., Savopoulos C., Myrou A., Manios E., Mavraganis G., Vemmou A., Kaitelidou D., Galanis P., Papastefanatos S., Konstantakopoulou O., Karagkouni I., Vemmos K. (2020)
      The aim of this study was to evaluate accessibility of stroke patients to optimal healthcare technology in Greece. Methods: The study population consisted of 313 first ever stroke patients derived from the 'Stroke Units ...

    • Advancements in the Treatment of Cerebrovascular Complications of Cancer 

      Aloizou A.-M., Siokas V., Mentis A.-F.A., Dastamani M., Sokratous M., Xiromerisiou G., Mitsias P.D., Hadjigeorgiou G.M., Dardiotis E. (2020)
      Purpose of review: To present the new guidelines and therapeutic options regarding cerebrovascular complications of cancer, mainly ischemic stroke, cerebral venous thrombosis (CVT), and leptomeningeal carcinomatosis (LMC). ...

    • Antiplatelet Resistance in Ischaemic Stroke Patients 

      Spanos K., Kouvelos G., Matsagkas M., Giannoukas A.D. (2017)
      [No abstract available]

    • ASTRAL-R score predicts non-recanalisation after intravenous thrombolysis in acute ischaemic stroke 

      Vanacker, P.; Heldner, M. R.; Seiffge, D.; Mueller, H.; Eskandari, A.; Traenka, C.; Ntaios, G.; Mosimann, P. J.; Sztajzel, R.; Pereira, V. M.; Cras, P.; Engelter, S.; Lyrer, P.; Fischer, U.; Lambrou, D.; Arnold, M.; Michel, P. (2015)
      Intravenous thrombolysis (IVT) as treatment in acute ischaemic strokes may be insufficient to achieve recanalisation in certain patients. Predicting probability of non-recanalisation after IVT may have the potential to ...

    • Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection 

      Iliopoulou M., Skouras V., Psaroudaki Z., Makarona M., Vogiatzakis E., Tsorlini E., Katsifa E., Spyratos D., Siopi D., Kotsiou O., Xitsas S., Martsoukou M., Sigala I., Kalomenidis I. (2021)
      Background: Community-acquired pleural infection (CAPI) is a growing health problem worldwide. Although most CAPI patients recover with antibiotics and pleural drainage, 20% require surgical intervention. The use of ...

    • EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: Basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry 

      Nordanstig A., Curtze S., Gensicke H., Zinkstok S.M., Erdur H., Karlsson C., Karlsson J.-E., Martinez-Majander N., Sibolt G., Lyrer P., Traenka C., Baharoglu M.I., Scheitz J.F., Bricout N., Hénon H., Leys D., Eskandari A., Michel P., Hametner C., Ringleb P.A., Arnold M., Fischer U., Sarikaya H., Seiffge D.J., Pezzini A., Zini A., Padjen V., Jovanovic D.R., Luft A., Wegener S., Kellert L., Feil K., Kägi G., Rentzos A., Lappalainen K., Leker R.R., Cohen J.E., Gomori J., Brehm A., Liman J., Psychogios M., Kastrup A., Papanagiotou P., Gralla J., Magoni M., Majoie C.B.L.M., Bohner G., Vukasinovic I., Cvetic V., Weber J., Kulcsar Z., Bendszus M., Möhlenbruch M., Ntaios G., Kapsalaki E., Jood K., Nolte C.H., Nederkoorn P.J.J., Engelter S., Strbian D., Tatlisumak T. (2021)
      Purpose The Thrombolysis in Ischemic Stroke Patients (TRISP) collaboration was a concerted effort initiated in 2010 with the purpose to address relevant research questions about the effectiveness and safety of intravenous ...

    • Gaps arising from randomized controlled trials on thrombolysis for proximal deep vein thrombosis of the lower limb 

      Nana P., Avgerinos E., Spanos K., Giannoukas A., Labropoulos N. (2022)
      [No abstract available]

    • Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration 

      Altersberger V.L., Rusche N., Martinez-Majander N., Hametner C., Scheitz J.F., Henon H., Dell'acqua M.L., Strambo D., Stolp J., Heldner M.R., Grisendi I., Jovanovic D.R., Bejot Y., Pezzini A., Leker R.R., Kägi G., Wegener S., Cereda C.W., Lindgren E., Ntaios G., Piot I., Polymeris A.A., Lyrer P.A., Räty S., Sibolt G., Tiainen M., Heyse M., Erdur H., Kaaouana O., Padjen V., Zedde M., Arnold M., Nederkoorn P.J., Michel P., Bigliardi G., Zini A., Cordonnier C., Nolte C.H., Ringleb P.A., Curtze S., Engelter S.T., Gensicke H., for the Thrombolysis in Stroke Patients (TRISP) Collaborators (2022)
      Background: The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely ...

    • Maintenance of Acute Stroke Care Service during the COVID-19 Pandemic Lockdown 

      Altersberger V.L., Stolze L.J., Heldner M.R., Henon H., Martinez-Majander N., Hametner C., Nordanstig A., Zini A., Nannoni S., Gonçalves B., Nolte C.H., Baumgartner P., Kastrup A., Papanagiotou P., Kägi G., Leker R.R., Zedde M., Padovani A., Pezzini A., Padjen V., Cereda C.W., Ntaios G., Bonati L.H., Rinkel L.A., Fischer U., Scheitz J.F., Wegener S., Turc G., Michel P., Gentile M., Rentzos A., Ringleb P.A., Curtze S., Cordonnier C., Arnold M., Nederkoorn P.J., Engelter S.T., Gensicke H., TRISP Collaborators (2021)
      BACKGROUND AND PURPOSE: Timely reperfusion is an important goal in treatment of eligible patients with acute ischemic stroke. However, during the coronavirus disease 2019 (COVID-19) pandemic, prehospital and in-hospital ...

    • Percutaneous patent foramen ovale closure for secondary stroke prevention: Network meta-analysis 

      Tsivgoulis G., Katsanos A.H., Mavridis D., Frogoudaki A., Vrettou A.-R., Ikonomidis I., Parissis J., Deftereos S., Karapanayiotides T., Palaiodimou L., Filippatou A., Perren F., Hadjigeorgiou G., Alexandrov A.W., Mitsias P.D., Alexandrov A.V. (2018)
      OBJECTIVE: Current guidelines report no benefit for patent foramen ovale (PFO) closure compared to medical treatment in patients with cryptogenic ischemic stroke (IS) or TIA. Two recent randomized controlled clinical trials ...

    • Prediction of long-term outcomes by arterial stiffness and pressure wave reflections in patients with acute stroke: the Athens Stroke Registry 

      Samara S., Vemmou A., Kyrkou A., Papamichael C., Korompoki E., Ntaios G., Manios E., Stamatelopoulos K., Protogerou A.D., Vemmos K. (2022)
      Background and purpose: Stroke patients' management might be improved by addressing the role of aortic stiffness (carotid-femoral pulse wave velocity: cfPWV) and pressure wave reflections (PWRs, augmentation index: AIx) ...

    • Predictors of Need for Critical Care Support, Adverse Events, and Outcome after Stroke Thrombolysis 

      Papamichalis P., Karagiannis S., Dardiotis E., Chovas A., Papadopoulos D., Zafeiridis T., Babalis D., Paraforos G., Zisopoulou V., Skoura A.-L., Staikos I., Bouliaris K., Papamichalis M., Hadjigeorgiou G., Komnos A. (2018)
      Background: Results from trials and international registries exhibit heterogeneity regarding safety, efficacy, markers of prognosis, and markers of the need for critical care support after intravenous thrombolysis (IVT) ...

    • Prior Dual Antiplatelet Therapy and Thrombolysis in Acute Stroke 

      Altersberger V.L., Sturzenegger R., Räty S., Hametner C., Scheitz J.F., Moulin S., van den Berg S.A., Zini A., Nannoni S., Heldner M.R., Jovanovic D.R., Martinez-Majander N., Tiainen M., Valkonen K., Berberich A., Erdur H., Cordonnier C., Peters N., Gopisingh K.M., Bigliardi G., Strambo D., De Marchis G.M., Ntaios G., Cereda C.W., Wegener S., Kägi G., Pezzini A., Padjen V., Arnold M., Michel P., Vandelli L., Nederkoorn P.J., Leys D., Nolte C.H., Ringleb P.A., Curtze S., Engelter S.T., Gensicke H. (2020)
      [No abstract available]

    • Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 

      Giustozzi M., Acciarresi M., Agnelli G., Caso V., Bandini F., Tsivgoulis G., Yaghi S., Furie K.L., Tadi P., Becattini C., Zedde M., Abdul-Rahim A.H., Lees K.R., Alberti A., Venti M., D'Amore C., Giulia Mosconi M., Anna Cimini L., Bovi P., Carletti M., Rigatelli A., Cappellari M., Putaala J., Tomppo L., Tatlisumak T., Marcheselli S., Pezzini A., Poli L., Padovani A., Vannucchi V., Sohn S.-I., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Ntaios G., Athanasakis G., Makaritsis K., Karagkiozi E., Vadikolias K., Liantinioti C., Theodorou A., Halvatsiotis P., Mumoli N., Galati F., Sacco S., Tiseo C., Corea F., Ageno W., Bellesini M., Silvestrelli G., Ciccone A., Lanari A., Scoditti U., Denti L., Mancuso M., Ferrari E., Ulivi L., Orlandi G., Giannini N., Tassinari T., Luisa De Lodovici M., Rueckert C., Baldi A., Toni D., Letteri F., Giuntini M., Maria Lotti E., Flomin Y., Pieroni A., Kargiotis O., Karapanayiotides T., Monaco S., Maimone Baronello M., Csiba L., Szabó L., Chiti A., Giorli E., Del Sette M., Imberti D., Zabzuni D., Doronin B., Volodina V., Michel P., Vanacker P., Barlinn K., Barlinn J., Deleu D., Gourbali V., Paciaroni M., Masotti L. (2020)
      Background and Purpose: The optimal timing for starting oral anticoagulant after an ischemic stroke related to atrial fibrillation remains a challenge, mainly in patients treated with systemic thrombolysis or mechanical ...

    • Thrombolysis and thrombectomy in patients treated with dabigatran with acute ischemic stroke: Expert opinion 

      Diener H.C., Bernstein R., Butcher K., Campbell B., Cloud G., Davalos A., Davis S., Ferro J.M., Grond M., Krieger D., Ntaios G., Slowik A., Touzé E. (2017)
      Systemic thrombolysis with rt-PA is contraindicated in patients with acute ischemic stroke anticoagulated with dabigatran. This expert opinion provides guidance on the use of the specific reversal agent idarucizumab followed ...

    • Thrombolysis for massive pulmonary embolism in a patient with hemorrhagic shock 

      Papanikolaou J., Spathoulas K., Makris D., Zakynthinos E. (2016)
      [No abstract available]

    • Thrombolysis in stroke patients with elevated inflammatory markers 

      Altersberger V.L., Enz L.S., Sibolt G., Hametner C., Nannoni S., Heldner M.R., Stolp J., Jovanovic D.R., Zini A., Pezzini A., Wegener S., Cereda C.W., Ntaios G., Räty S., Gumbinger C., Heyse M., Polymeris A.A., Zietz A., Schaufelbuehl A., Strambo D., Padlina G., Slavova N., Tiainen M., Valkonen K., Velzen T.J., Bigliardi G., Stanarcevic P., Magoni M., Luft A., Bejot Y., Vandelli L., Padjen V., Nederkoorn P.J., Arnold M., Michel P., Ringleb P.A., Curtze S., Engelter S.T., Gensicke H., for the Thrombolysis in Stroke Patients (TRISP) collaborators (2022)
      Objective: To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality and bleeding risk in stroke patients treated with intravenous thrombolysis (IVT). Methods: In this prospective ...